Prognostic signature analysis and survival prediction of esophageal cancer based on N6-methyladenosine associated lncRNAs
Briefings in Functional Genomics · 2024
DOI: 10.1093/bfgp/elad028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Functional Genomics, 2024. Verfasst von Ting He und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematics and Statistics, Southwest University, Chongqing 400715, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Adenosine, Esophageal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Esophageal cancer (ESCA) has a bad prognosis. Long non-coding RNA (lncRNA) impacts on cell proliferation. However, the prognosis function of N6-methyladenosine (m6A)-associated lncRNAs (m6A-lncRNAs) in ESCA remains unknown. Univariate Cox analysis was applied to investigate prognosis related m6A-lncRNAs, based on which the samples were clustered. Wilcoxon rank and Chi-square tests were adopted to compare the clinical traits, survival, pathway activity and immune infiltration in different clusters where overall survival, clinical traits (N stage), tumor-invasive immune cells and pathway activity were found significantly different. Through least absolute shrinkage and selection operator and proportional hazard (Lasso-Cox) model, five m6A-lncRNAs were selected to construct the prognostic signature (m6A-lncSig) and risk score. To investigate the link between risk score and clinical traits or immunological microenvironments, Chi-square test and Spearman correlation analysis were utilized. Risk score was found connected with N stage, tumor stage, different clusters, macrophages M2, B cells naive and T cells CD4 memory resting. Risk score and tumor stage were found as independent prognostic variables. And the constructed nomogram model had high accuracy in predicting prognosis. The obtained m6A-lncSig could be taken as potential prognostic biomarker for ESCA patients. This study offers a theoretical foundation for clinical diagnosis and prognosis of ESCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Mathematics and Statistics, Southwest University, Chongqing 400715, China.
- Beidahuang Industry Group General Hospital, Harbin 150000, China.
- Yucai School Attached to Sichuan Chengdu No. 7 High School, Chengdu 610503, China.
- Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu 611730, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, T., Gao, Z., Lin, L., Zhang, X., & Zou, Q. (2024). Prognostic signature analysis and survival prediction of esophageal cancer based on N6-methyladenosine associated lncRNAs. Briefings in Functional Genomics. https://doi.org/10.1093/bfgp/elad028
Vancouver
He T, Gao Z, Lin L, Zhang X, Zou Q. Prognostic signature analysis and survival prediction of esophageal cancer based on N6-methyladenosine associated lncRNAs. Briefings in Functional Genomics. 2024. doi:10.1093/bfgp/elad028
BibTeX
@article{He2024,
author = {He, Ting and Gao, Zhipeng and Lin, Ling and Zhang, Xu and Zou, Quan},
title = {Prognostic signature analysis and survival prediction of esophageal cancer based on N6-methyladenosine associated lncRNAs},
journal = {Briefings in Functional Genomics},
year = {2024},
doi = {10.1093/bfgp/elad028}
}
EUVIMED